Company intelligence / Profile preview

Shanghai Aikangte Medical Technology

Shanghai, Shanghai Municipality, China

Ownership: Private
Development stage: Other

Overview

Shanghai Aikangte Medical Technology has developed innovative ophthalmic medical devices. Its Rigid Scleral Contact Lens was approved by the China NMPA in September 2023. The lens features a novel double sagittal deep asymmetric design for improved fit and comfort, targeting patients with significant refractive errors or irregular astigmatism. The company is active in developing solutions for vision correction and eye health.

Therapeutic areas: Ophthalmology
Modalities: Device (specifically ophthalmic devices, including contact lenses and diagnostic equipment)
Industry: Assistive Medical Devices

Beyond the preview

Go deeper on Shanghai Aikangte Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Aikangte Medical Technology.

Explore the full profile